Sales & Marketing News | pharmaphorum

News

GSK et al win another round in Zantac cancer litigation

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also

News

FDA clears Rexulti as first drug for Alzheimer’s agitation

Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodege

News

Changing Faces: Pharma and biotech hires from April 2023

The month of April was a bit lighter in quantity of hires, but those we did see were high-profile: pharma and biotech saw at least four CEO changes, as well as numerous board chairs.

News

Investment group will take Syneos Health private

Contract research organisation (CRO) Syneos Health has agreed to be acquired by a group of investors, in the second multibillion-dollar takeover of a pharma outsourcing bu

News

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibro

News